COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD FOR THE SELECTIVE ACTIVATION / STIMULATION OF A-7 NICOTINIC RECEPTORS IN A PATIENT, METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM A PSYCHOTIC DISEASE, A DISEASES AND A NEURODEGENERATIVE DISEASE. OR A CONDITION OF DEGENERATION OF MEMORY AND / OR COGNITION, METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM DEMENTIA AND / OR ANOTHER CONDITION WITH LOSS OF MEMORY, METHOD FOR TREATING A PATIENT SUFFERING DEGENERATION OF DEATH MEMORY SOFT COGNITIVE DEGENERATION DUE TO AGING, ALZHEIMER EVIL, SCHIZOPHRENIA, PARKINSON EVIL, HUNTINGTON EVIL, PICK EVIL, CREUTZFELDT-JAKOB EVIL, DEPRESSION, AGING, SICKNESS, HARMONY, HARMONY, ACCIDENT, HEALTH, HEALTH MULTIINFARTO DEMENTIA, HIV AND / OR CARDIOVASCULAR DISEASE, METHOD FOR TREATING AND / OR PREVENTING DEMENTIA IN A PATIENT WITH ALZHEIMER'S EVIL , METHOD FOR THE TREATMENT OF A PATIENT FOR THE WITHDRAWAL OF ALCOHOL OR FOR THE TREATMENT OF A PATIENT WITH ANTI-TOXIC THERAPY, METHOD FOR THE TREATMENT OF

摘要

COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD FOR THE SELECTIVE ACTIVATION / STIMULATION OF A-7 NICOTINIC RECEPTORS IN A PATIENT, METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM A PSYCHOTIC DISEASE, A DISEASES AND A NEURODEGENERATIVE DISEASE. OR A CONDITION OF DEGENERATION OF MEMORY AND / OR COGNITION, METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM DEMENTIA AND / OR ANOTHER CONDITION WITH LOSS OF MEMORY, METHOD FOR TREATING A PATIENT SUFFERING DEGENERATION OF DEATH MEMORY SOFT COGNITIVE DEGENERATION DUE TO AGING, ALZHEIMER'S EVIL, SCHIZOPHRENIA, PARKINSON'S EVIL, HUNTINGTON'S EVIL, PICK'S EVENT, CREUTZFELDT-JAKOB EVIL, DEPRESSION, AGING, SICKNESS, HARMONY, HARMONY, ACCIDENT, HEALTH, HEALTH MULTIINFARTO DEMENTIA, HIV AND / OR CARDIOVASCULAR DISEASE, METHOD FOR TREATING AND / OR PREVENTING DEMENTIA IN A PATIENT WITH ALZHEIMER'S EVIL , METHOD FOR THE TREATMENT OF A PATIENT FOR THE WITHDRAWAL OF ALCOHOL OR FOR THE TREATMENT OF A PATIENT WITH ANTI-TOXIC THERAPY, METHOD FOR THE TREATMENT OF A PATIENT TO CONFIRM NEUROPROTECTION AGAINST DAMAGE ASSOCIATED WITH CEREBRAL EARLY ACCIDENT RESULTS GLUTAMATE, METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM NICOTIN ADDICTION, PAIN, TIME DIFFERENCE, OBESITY AND / OR DIABETES, METHOD OF INDUCING A PATIENT TO STOP SMOKING, METHOD FOR TREATING A PATIENT WHO SUFFERS SOFT COGNITIVE DEGENERATION (MCI), VASCULAR DEMENTIA (VAD), COGNITIVE DECLINATION ASSOCIATED WITH AGE (AACD), AMNESIA ASSOCIATED WITH OPEN HEART SURGERY, CARDIAC APPROPRIATION, GENERAL ANESTHESIA, DEHESIA, DEHESIA, HOSPITAL SLEEP INDUCED BY COGNITIVE DEGENERATION, CHRONIC FATIGUE SYNDROME, NARCOLEPSY, AIDS-RELATED DEMENTIA, RELATED COGNITIVE DEGENERATION OF WITH EPILEPSY, DOWN SYNDROME, DEMENTIA RELATED TO ALCOHOLISM, DRUG / SUBSTANCES-DEGENERATION, PUGILISTIC DEMENTIA (BOXEATER SYNDROME), OR ANIMAL DEMENTIA, METHOD FOR TREATING TREATMENT TREATMENT METHOD A PATIENT SUFFERING FROM MEMORY DEGENERATION, METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A DISEASE OR A CONDITION RESULTING FROM THE DISCURSION OF THE TRANSMISSION OF THE NICOTINIC ACETYLINE RECEPTOR IN A PATIENT, METHOD FOR THE TREATMENT OR A PROFILE OF PROFILE RESULTING FROM DEFECTIVE ACETYL CHILLINE NICOTINIC RECEPTORS OR MALFUNCTIONING IN A PATIENT, METHOD FOR TREATING OR PROPHYLAXIS OF A DISEASE OR A CONDITION RESULTING FROM THE DELETED TRANSMISSION OF THE ACETYLINE COLIN RECEIVER TO A NICOTYLINIC TREATMENT INTO A NICOTINIC TREATMENT OR A NICOTININE TREATMENT. A DISEASE OR CONDITION RESULTING FROM THE LOSS OF CHOLINERGIC SYNOPSIS IN A PATIENT, METHOD O FOR THE PROTECTION OF NEURONES IN A PATIENT WITH NEUROTOXICITY INDUCED BY THE ACTIVATION OF A7NACH RECEPTORS, METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A NEURODEGENERATIVE DISORDER THROUGH THE INHIBITION OF THE PEEPIDE CONTAINED WITH AEPETHESIS OF AEPHESIS OF AEPHESIS OF AEPHESIS OF AEPHESIS. TREATMENT OF A PATIENT SUFFERING FROM AN INFLAMMATORY DISEASE The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), the activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetyl choline receptors, especially in the brain. In addition, the present invention relates to new compounds (for example, indazoles and benzothiazoles), which act as ligands for the cx7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of using them.